Redsense Medical AB (publ) (XSAT:REDS)
3.200
-0.030 (-0.93%)
At close: Aug 26, 2026
Redsense Medical AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -0.65 | -7.17 | 0.34 | -4.51 | -8.76 | -7.97 |
Depreciation & Amortization | 0.75 | 0.07 | 0.07 | 0.06 | 0.05 | 0.03 |
Other Amortization | 0.56 | 0.56 | - | - | - | 0.15 |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | - | - | - | - |
Stock-Based Compensation | 0.02 | 0.02 | - | - | - | - |
Other Operating Activities | 0.08 | 1.85 | -1.08 | -1.58 | -0.08 | -2.29 |
Change in Accounts Receivable | -3.78 | -0.57 | -1.73 | 0.98 | -1.29 | -1.08 |
Change in Inventory | -3.39 | -2.72 | -4.63 | 0.18 | -0.1 | 0.91 |
Change in Other Net Operating Assets | -1.1 | 2.76 | -1.2 | -0.17 | 0.4 | -1.97 |
Operating Cash Flow | -7.52 | -5.2 | -8.23 | -5.05 | -9.78 | -12.22 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.04 | -0.03 | -0.02 | -0.05 | -0.05 | -0.36 |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | - | - | - |
Sale (Purchase) of Intangibles | -2.53 | -2.78 | -0.59 | -0.55 | -2.41 | -8.86 |
Investment in Securities | - | - | - | 8.95 | 13.33 | -0.5 |
Other Investing Activities | - | - | - | - | - | -0 |
Investing Cash Flow | -2.56 | -2.8 | -0.61 | 8.35 | 10.87 | -9.71 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | - | 2.57 |
Long-Term Debt Repaid | - | - | - | - | -2.57 | - |
Net Debt Issued (Repaid) | - | - | - | - | -2.57 | 2.57 |
Issuance of Common Stock | - | - | 17.23 | - | - | - |
Common Dividends Paid | - | - | - | - | - | -4.46 |
Other Financing Activities | - | - | - | - | 0.18 | - |
Financing Cash Flow | - | - | 17.23 | - | -2.4 | -1.89 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.21 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 | - |
Net Cash Flow | -10.08 | -8 | 8.39 | 3.29 | -1.31 | -24.02 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.56 | -5.23 | -8.25 | -5.1 | -9.83 | -12.58 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -28.57% | -21.77% | -29.27% | -20.44% | -68.55% | -134.38% |
Free Cash Flow Per Share | -0.42 | -0.29 | -0.48 | -0.36 | -0.70 | -0.90 |
Levered Free Cash Flow | -10.04 | -5.02 | -9.22 | -2.73 | -9.9 | -19.17 |
Unlevered Free Cash Flow | -10.02 | -5 | -9.2 | -2.71 | -9.84 | -19.13 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | -8.27 | -0.52 | -7.56 | 0.98 | -1 | -2.13 |